FDA Approved: FENOFIBRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for fenofibrate submitted by Mylan Pharmaceuticals Inc., for a generic fenofibrate product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysbetalipoproteinemia
• Dyslipidemia Mixed
• Hyperlipidemia
• Hypertriglyceridemia
• Pancreatitis

Drugs mentioned

• FENOFIBRATE (Fenofibrate)

Snippet

SUPPL AP for FENOFIBRATE (FENOFIBRATE)